Comparing standard screening questionnaires of canine behavior for assessment of cognitive dysfunction
- PMID: 38835892
- PMCID: PMC11149356
- DOI: 10.3389/fvets.2024.1374511
Comparing standard screening questionnaires of canine behavior for assessment of cognitive dysfunction
Abstract
Background: Canine cognitive dysfunction (CCD) is a common, yet underdiagnosed neurodegenerative disease affecting older dogs. Treatment is most effective when started early, so identifying mild cognitive decline in the earlier stages of the disease is considered important.
Hypothesis/objective: To compare the results of three different standard screening questionnaires [Canine Dementia Scale (CADES), Canine Cognitive Assessment Scale (CCAS), and Canine Cognitive Dysfunction Rating Scale (CCDR)] for CCD diagnosis. Trainability, pain sensitivity, and fear were additionally assessed with the Canine Behavioral Assessment and Research Questionnaire (C-BARQ) in order to evaluate associations between the three dementia scales and behavior.
Methods: An online survey containing all the mentioned questionnaires was designed for and distributed among owners of elderly dogs.
Results: Data from 597 dogs were analyzed. Overall, the scores of the three CCD questionnaires correlated well with each other, especially those of the CADES and CCAS. The CADES was more sensitive in identifying dogs with already mild to moderate cognitive impairment, while the others classified them as still undergoing normal aging. CCD scores increased for all questionnaires with age with spatial orientation being a key feature in CCD development. Trainability assessed with the C-BARQ decreased significantly with severity of CCD signs, while pain sensitivity increased. Fear and anxiety was pronounced in animals with mild but not with severe CCD. These associations based on the C-BARQ were more clearly observable in relation to CADES and CCDR than CCAS.
Conclusion/clinical relevance: The choice of screening questionnaire impacts the evaluation of cognitive status and severity of CCD. Thresholds for severity classification differ significantly and may have an impact on reliable assessment. Further longitudinal studies are required to determine which of the questionnaires investigated in this study is best suited for early detection of CCD.
Keywords: assessment tools; canine dementia; cognition; geriatrics; questionnaire.
Copyright © 2024 Haake, Meller, Meyerhoff, Twele, Charalambous, Talbot and Volk.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures












Similar articles
-
Use of Cognitive Testing, Questionnaires, and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population.J Alzheimers Dis. 2022;87(3):1367-1378. doi: 10.3233/JAD-215562. J Alzheimers Dis. 2022. PMID: 35431246 Free PMC article.
-
Physical signs of canine cognitive dysfunction.J Vet Med Sci. 2019 Dec 26;81(12):1829-1834. doi: 10.1292/jvms.19-0458. Epub 2019 Nov 1. J Vet Med Sci. 2019. PMID: 31685716 Free PMC article.
-
Relationship between engagement with the impossible task, cognitive testing, and cognitive questionnaires in a population of aging dogs.Front Vet Sci. 2023 Jan 4;9:1052193. doi: 10.3389/fvets.2022.1052193. eCollection 2022. Front Vet Sci. 2023. PMID: 36686191 Free PMC article.
-
Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment.Vet Clin North Am Small Anim Pract. 2019 May;49(3):477-499. doi: 10.1016/j.cvsm.2019.01.013. Epub 2019 Mar 5. Vet Clin North Am Small Anim Pract. 2019. PMID: 30846383 Review.
-
Transcranial photobiomodulation (laser) therapy for cognitive impairment: A review of molecular mechanisms and potential application to canine cognitive dysfunction (CCD).Open Vet J. 2022 Mar-Apr;12(2):256-263. doi: 10.5455/OVJ.2022.v12.i2.14. Epub 2022 Apr 17. Open Vet J. 2022. PMID: 35603072 Free PMC article. Review.
Cited by
-
Comparative analysis of chronic neuropathic pain and pain assessment in companion animals and humans.Front Vet Sci. 2024 Dec 10;11:1520043. doi: 10.3389/fvets.2024.1520043. eCollection 2024. Front Vet Sci. 2024. PMID: 39720411 Free PMC article. Review.
-
Evaluation of Blood-Based Diagnostic Biomarkers for Canine Cognitive Dysfunction Syndrome.Animals (Basel). 2025 Jul 4;15(13):1974. doi: 10.3390/ani15131974. Animals (Basel). 2025. PMID: 40646873 Free PMC article.
-
Diagnosis of Canine Cognitive Dysfunction Syndrome: A Narrative Review.Vet Sci. 2025 Aug 20;12(8):781. doi: 10.3390/vetsci12080781. Vet Sci. 2025. PMID: 40872731 Free PMC article. Review.
References
-
- Osella MC, Re G, Odore R, Girardi C, Badino P, Barbero R, et al. . Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci. (2007) 105:297–310. doi: 10.1016/j.applanim.2006.11.007 - DOI
LinkOut - more resources
Full Text Sources